Sticky platelet syndrome and thrombocythemia.
Platelets are intimately involved in the pathogenesis of thromboembolic disorders, especially arterial forms of thrombosis. Although most arterial thromboses develop on the basis of endothelial injuries, some do not. In these instances "hyperactive" platelets could be the cause. Hyperaggregable platelets have been described in association with a number of acquired disease entities whereby the cause-and-effect relationship is unclear. In contrast, the sticky platelet syndrome is a congenital, autosomal dominant disorder, characterized by hyperaggregable platelets in response to ADP, epinephrine, or both. Patients usually seek treatment for transient or permanent arterial vascular occlusions. These are often precipitated by stressful events. Treatment with low-dose aspirin (81 mg/day) reverses clinical symptoms and hyperaggregability in the laboratory.
Frenkel
Eugene P
EP
Department of Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8852, USA. Eugene.frenkel@UTSouthwestern.edu
Mammen
Eberhard F
EF
D006801:Humans; D010974:Platelet Aggregation; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D013577:Syndrome; D013922:Thrombocytosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D013927:Thrombosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*
D010975:Platelet Aggregation Inhibitors